NCT00299026View on ClinicalTrials.gov

A Randomized, Double-Blind, Controlled Study of the Safety and Performance of the NIRx™ Paclitaxel-Coated Conformer Coronary Stent

PHASE2CompletedINTERVENTIONAL
Enrollment

532

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

May 31, 2003

Study Completion Date

February 28, 2007

Conditions
Coronary Artery Disease
Interventions
DEVICE

NIRx(TM) Paclitaxel-Coated Conformer Coronary Stent System

Trial Locations (1)

20132

San Raffaele del Monte Tabor, Milan

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY